Ozanimod: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ozanimod. Educational only — not medical advice.
Labeled uses
ZEPOSIA is indicated for the treatment of: relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. moderately to severely active ulcerative colitis (UC) in adults.
Source: FDA labeling via NIH DailyMed (set 93ce2fab…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.